{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:23:57Z","timestamp":1761906237723,"version":"build-2065373602"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mycosis fungoides, the most common cutaneous T-cell lymphoma, typically exhibits a gradual progression. However, aggressive forms with extracutaneous involvement and low proliferative indices may present diagnostic and prognostic challenges. Nail involvement appears to be infrequent and poorly understood, and is often considered a late-stage manifestation. The Ki-67 index, although frequently utilized as an indicator of tumor aggressiveness, may have limitations in specific mycosis fungoides subtypes that appear to be influenced by distinct molecular or immunological pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We present a 62-year-old Iranian woman with early stage mycosis fungoides, exhibiting erythematous abdominal plaques, pruritus, and early onset onychodystrophy. Within 4 months, the lesions rapidly progressed to painful plaques affecting the face and intertriginous areas. The initial biopsy revealed features consistent with plaque-stage mycosis fungoides, characterized by CD4 predominance, CD7 deficiency, and a low Ki-67 index (&lt;\u20095%). Despite low proliferation indices, the disease progressed rapidly. Imaging revealed bilateral lymphadenopathy, and a subsequent biopsy confirmed ongoing disease, with limited CD8 expression, absent B-cell markers, and Ki-67 levels of 1\u20133%. The treatment regimen comprised methotrexate, interferon-alpha, and psoralen and ultraviolet A therapy. Partial cutaneous response was achieved; however, systemic progression occurred. Laboratory results revealed leukocytosis, elevated lactate dehydrogenase levels, and hepatic impairment. Bone marrow biopsies suggested early dissemination. Peripheral blood flow cytometry and nail biopsy were not conducted. The patient ultimately developed multiorgan failure and was transitioned to palliative care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case suggests the potential for aggressive mycosis fungoides behavior despite indolent histopathological characteristics. Initial nail involvement might serve as a clinical marker of atypical progression. The limitations of Ki-67 alone suggest the need for comprehensive prognostic models that incorporate molecular biomarkers, such as thymocyte selection-associated high mobility group box, CD30, and T-cell receptor clonality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-025-05582-8","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:20:30Z","timestamp":1761906030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early nail involvement in mycosis fungoides with rapid systemic progression: rethinking the role of Ki-67: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Shafagh","family":"Ali Asgarzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1546-9286","authenticated-orcid":false,"given":"Amir Arshia","family":"Beheshti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"5582_CR1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65034","author":"V Hagan","year":"2024","unstructured":"Hagan V, Myers E, Caussat T, Sobhan A, Barrueto L, Awan A. Atypical cutaneous manifestation of mycosis fungoides: a case report. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.65034.","journal-title":"Cureus"},{"issue":"4","key":"5582_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.56305\/001c.85106","volume":"2","author":"L Ojeaburu","year":"2023","unstructured":"Ojeaburu L, Larsen T. Mycosis fungoides. J Brown Hosp Med. 2023;2(4):85\u2013106.","journal-title":"J Brown Hosp Med"},{"key":"5582_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19913","author":"F Hali","year":"2021","unstructured":"Hali F, Berchmans NJ, Marnissi F, Asma EK, Chiheb S, Berchmans NJ. Nail mycosis fungoides: a new case. Cureus. 2021. https:\/\/doi.org\/10.7759\/cureus.19913.","journal-title":"Cureus"},{"issue":"15","key":"5582_CR4","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3578","volume":"100","author":"L Atzmony","year":"2020","unstructured":"Atzmony L, Moyal L, Feinmesser M, Gorovitz B, Hirshberg A, Amitay-Laish I, et\u00a0al. Stage-dependent increase in expression of mir-155 and ki-67 and number of tumour-associated inflammatory cells in folliculotropic mycosis fungoides. Acta Dermato-Venereol. 2020;100(15): 5828.","journal-title":"Acta Dermato-Venereol"},{"issue":"1","key":"5582_CR5","first-page":"189","volume":"36","author":"A Jankowska-Konsur","year":"2016","unstructured":"Jankowska-Konsur A, Kobierzycki C, Reich A, Grzegrzolka J, Bieniek A, Dziegiel P. Expression of SATB1, MTI\/II and Ki-67 in mycosis fungoides. Anticancer Res. 2016;36(1):189\u201397.","journal-title":"Anticancer Res"},{"issue":"6","key":"5582_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.4103\/ijdvl.IJDVL_1011_18","volume":"87","author":"MA-H Ibrahim","year":"2021","unstructured":"Ibrahim MA-H, Mohamed A, Soltan MY. Thymocyte selection-associated high-mobility group box as a potential diagnostic marker differentiating hypopigmented mycosis fungoides from early vitiligo: a pilot study. Indian J Dermatol Venereol Leprol. 2021;87(6):819\u201325.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"5582_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/cup.14557","volume":"51","author":"S \u00d6rnek","year":"2024","unstructured":"\u00d6rnek S, Ozekinci S, Ipin T, Kocaturk E. TOX, TWIST1, STAT4, and SATB1 protein expressions in early-stage mycosis fungoides. J Cutan Pathol. 2024;51(3):232\u20138.","journal-title":"J Cutan Pathol"},{"issue":"7","key":"5582_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/diagnostics12071582","volume":"12","author":"A Pileri","year":"2022","unstructured":"Pileri A, Cavicchi M, Bertuzzi C, Righi S, Zengarini C, Sabattini E, et\u00a0al. TOX expression in mycosis fungoides and Sezary syndrome. Diagnostics. 2022;12(7):1582.","journal-title":"Diagnostics"},{"issue":"1","key":"5582_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1158\/2326-6066.CIR-20-0236","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang X, Huynh C, Urak R, Weng L, Walter M, Lim L, et\u00a0al. The cerebroventricular environment modifies CAR T cells for potent activity against both central nervous system and systemic lymphoma. Cancer Immunol Res. 2021;9(1):75\u201388.","journal-title":"Cancer Immunol Res"},{"issue":"12","key":"5582_CR10","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1182\/bloodadvances.2023012125","volume":"8","author":"L Fl\u00e9chon","year":"2024","unstructured":"Fl\u00e9chon L, Arib I, Dutta AK, Hasan Bou Issa L, Sklavenitis-Pistofidis R, Tilmont R, et\u00a0al. Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression. Blood Adv. 2024;8(12):3109\u201319.","journal-title":"Blood Adv"},{"issue":"1","key":"5582_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/biomedicines13010186","volume":"13","author":"A Johansson","year":"2025","unstructured":"Johansson A, Kalliara E, Belfrage E, Alling T, Pyl PT, Gerdtsson AS, et\u00a0al. The progression of mycosis fungoides during treatment with Mogamulizumab: a BIO-MUSE case study of the tumor and immune response in peripheral blood and tissue. Biomedicines. 2025;13(1):186.","journal-title":"Biomedicines"},{"issue":"9","key":"5582_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.85","volume":"7","author":"C Van der Weyden","year":"2017","unstructured":"Van der Weyden C, Pileri S, Feldman A, Whisstock J, Prince H. Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions. Blood Cancer J. 2017;7(9): e603.","journal-title":"Blood Cancer J"},{"issue":"19","key":"5582_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000042279","volume":"104","author":"L Liu","year":"2025","unstructured":"Liu L, Zhang X. A comprehensive update of extracutaneous involvement of mycosis fungoides: a narrative review of literature. Medicine (Baltimore). 2025;104(19): e42279.","journal-title":"Medicine (Baltimore)"},{"issue":"19","key":"5582_CR14","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3390\/cancers16193380","volume":"16","author":"R Abdel Tawab","year":"2024","unstructured":"Abdel Tawab R, Rajy J, Abdallat S, Almurrawi MA, Al Farsi K, Alassaf J, et\u00a0al. The landscape of cutaneous T-cell lymphoma (CTCL) in the Middle East and North Africa (MENA) and the establishment of the MENA CTCL working group. Cancers. 2024;16(19):3380.","journal-title":"Cancers"},{"key":"5582_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","volume":"89","author":"DS Riley","year":"2017","unstructured":"Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, et\u00a0al. Care guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218\u201335.","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05582-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:20:31Z","timestamp":1761906031000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05582-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5582"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05582-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Research Ethics Committee of Ardabil University of Medical Sciences with the ethical code IR.ARUMS.REC.1404.104 on 22 April 2025.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"560"}}